MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.chest.2026.06.075

Медицинская библиотека · Chest · 2026

Septic shock after allogeneic hematopoietic stem-cell transplantation: outcomes and prognostic factors in a multicenter ICU cohort.

Subileau Marielle, Chean Dara, Dupont Thibault, Canet Emmanuel, Moreau Anne-Sophie, Picard Muriel, Mokart Djamel, Platon Laura, Mayaux Julien, Wallet Florent, Issa Nahema, Raphalen Jean-Herlé, Pène Frédéric, Renault Anne, Arnales Delphine, Van De Wyngaert Caroline, Kemp Hélène, Xhaard Aliénor, Bigé Naike, Darmon Michaël, Azoulay Elie, Lafarge Antoine

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Septic shock is a major cause of intensive care unit (ICU) admission among allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, yet data on its epidemiology and prognosis remain limited.

RESEARCH QUESTION: We aimed to describe outcomes, identify independent prognostic factors, and explore associations that may inform early management.

STUDY DESIGN AND

METHODS

We performed a multicenter retrospective cohort study including allo-HSCT recipients admitted to the ICU with septic shock between 2015 and 2020.

RESULTS

Among 1,164 allo-HSCT recipients hospitalized in ICU, 38% (n=444) were admitted for septic shock. The median SOFA score was 8 (IQR, 6-11). Microbiological documentation was obtained in 62% (n=261), including fungal pathogens in 17% (n=74). The respiratory tract was the most common infection source (43%, n=180). Invasive mechanical ventilation and renal replacement therapy were required in 64% (n=284) and 32% (n=143), respectively. Mortality at 90 days and 3 years was 63% (n=280) and 81% (n=350). In the extended Cox model, fungal documentation (HR 1.78 [95% CI, 1.19-2.67], p=0.005), SOFA score (HR 1.07 [95% CI, 1.02-1.13], p=0.007), and neutropenia (HR 3.94 [95% CI, 1.18-13.1], p=0.026) were independently associated with 90-day survival. In a 48-hour landmark analysis, early aminoglycoside use was associated with higher 90-day survival (HR 0.46 [95% CI, 0.33-0.64], p<0.001). However, time-varying analyses indicated a non-constant association over time. Age ≥ 56 years (HR 1.36, [95% CI, 0.99-1.87]), GvHD type, and early bacterial documentation (HR 0.90, [95% CI, 0.64-1.26]) were not associated with 90-day survival.

INTERPRETATION: Septic shock after allo-HSCT carries a high mortality (63% at 90 days), largely driven by host-related factors and initial illness severity. The association between aminoglycoside use and outcome is complex, does not support a straightforward causal interpretation, and warrants further prospective evaluation.

Для цитирования: Subileau Marielle, Chean Dara, Dupont Thibault, Canet Emmanuel, Moreau Anne-Sophie, Picard Muriel, Mokart Djamel, Platon Laura, Mayaux Julien, Wallet Florent, Issa Nahema, Raphalen Jean-Herlé, Pène Frédéric, Renault Anne, Arnales Delphine, Van De Wyngaert Caroline, Kemp Hélène, Xhaard Aliénor, Bigé Naike, Darmon Michaël, Azoulay Elie, Lafarge Antoine. Septic shock after allogeneic hematopoietic stem-cell transplantation: outcomes and prognostic factors in a multicenter ICU cohort.. Chest. 2026. DOI: 10.1016/j.chest.2026.06.075.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.